Vaccinex Profit Margin

Vaccinex (VCNX) currently reports a profit margin of -3100.5% as of December 2024. That compares with -10992.93% in the prior-year period — up 71.8% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Vaccinex's profit margin history and peer comparisons.

Vaccinex's profit margin increased from -10992.93% to -3100.5% — a 71.8% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vaccinex's profit margin of -3100.5% is lower than the Healthcare sector average of 13.89%. That is roughly 22416.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Vaccinex's current -3100.5% should be judged against Healthcare norms (sector average: 13.89%) and against VCNX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -3100.5%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Vaccinex, and consider following VCNX for alerts when major investors trade the stock.